• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Madrigal Pharmaceuticals Inc (NQ: MDGL )

    279.53 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 21
    Open 279.53
    Bid (Size) 269.00 (1)
    Ask (Size) 306.88 (1)
    Prev. Close 279.53
    Today's Range 279.53 - 279.53
    52wk Range 119.76 - 299.98
    Shares Outstanding 17,103,395
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    7 Biotech Stocks to Keep on Your Clinical Radar
    Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. 
    Via InvestorPlace
    Is Madrigal Pharmaceuticals a Millionaire Maker?
    Its revenue ramp-up is just starting, and its market looks lucrative. 
    Via The Motley Fool

    Performance

    YTD
    +23.22%
    +23.22%
    1 Month
    -1.57%
    -1.57%
    3 Month
    +28.00%
    +28.00%
    6 Month
    +22.07%
    +22.07%
    1 Year
    +35.91%
    +35.91%

    More News

    Read More
    Is Madrigal Pharmaceuticals Stock a Buy?
    Via The Motley Fool
    The Best Biotech Stock to Invest $1,000 in Right Now
    Via The Motley Fool
    Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
    Via Investor's Business Daily
    Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
    Via The Motley Fool
    Is Madrigal Pharmaceuticals Stock a Buy?
    Via The Motley Fool
    2 Under-the-Radar Growth Stocks to Consider
    Via The Motley Fool
    1 No-Brainer Growth Stock to Buy Now
    Via The Motley Fool
    Where Will Madrigal Pharmaceuticals Be in 3 Years?
    Via The Motley Fool
    Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
    Via Investor's Business Daily
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
    Via The Motley Fool
    What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
    Via Benzinga
    Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH
    Via Investor's Business Daily
    DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
    Via Investor's Business Daily
    The Week Ahead: What's Next
    Via Talk Markets
    MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    6 Stocks Positioned to Soar as Investors Focus on MASH
    Via TheNewswire.com
    7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024
    Via InvestorPlace
    Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
    Via The Motley Fool
    The 3 Best Biotech Stocks to Buy in April 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.